JCP

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH REGISTER
[Advanced]

J Clin Pathol. Published Online First: 12 May 2008. doi:10.1136/jcp.2007.054643
Copyright © 2008 by the BMJ Publishing Group Ltd & Association of Clinical Pathologists.

This Article
Right arrow Full Text (Rapid PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Google Scholar
Right arrow Articles by Hanna Morris, A.
Right arrow Articles by Allen-Mersh, T.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hanna Morris, A.
Right arrow Articles by Allen-Mersh, T.

Histopathology

MINICHROMOSOME MAINTENANCE PROTEIN 2 (MCM2) IS A STRONGER DISCRIMINATOR OF INCREASED PROLIFERATION IN MUCOSA ADJACENT TO COLORECTAL CANCER THAN Ki-67

Alys Hanna Morris 1*, Sara Badvie 1, Patrizia Cohen 1, Timothy McCullough 1, H J N Andreyev 1 and Timothy Allen-Mersh 1

1 Imperial College London, United Kingdom

* To whom correspondence should be addressed. E-mail: a.hanna{at}imperial.ac.uk.

Accepted 21 April 2008


*   Abstract

Background: Loss of control of mucosal crypt cell proliferation resulting in a hyperproliferative field change occurs early in the adenoma-carcinoma sequence. Ki-67, the current gold-standard marker of cellular proliferation, is a cell cycle protein that may lack sensitivity in demonstrating altered mucosal crypt cell dynamics. Minichromosome maintenance protein 2 (MCM2) has a specific role in DNA replication and has been proposed as a new marker for screening for colorectal cancer. Aim: To compare the expression of Ki-67 with MCM2 in colorectal mucosa associated with colorectal cancer. Methods: Ki-67 and MCM2 immunostaining was performed on serial sections taken from formalin-fixed, paraffin-embedded specimens. Labelling indices (LI’s) were calculated by counting the proportion of positively stained nuclei in representative areas of adenocarcinoma, and in equivalent superficial, middle, and basal crypt compartments of mucosa sampled 1cm from the tumour (Ca1) and 10cm from the tumour (Ca10). Results: Specimens were obtained from 43 patients. Most nuclei in specimens of adenocarcinoma stained positively for MCM2 and Ki-67. In Ca1 and Ca10 samples significantly greater staining was seen in all crypt compartments with MCM2 compared with Ki-67. Receiver operator characteristic curve analysis suggested that proliferation changes (assessed either by MCM2 or by Ki-67) in Ca10 but not Ca1 mucosa significantly predicted for origin from a carcinoma-associated colon. Conclusions: MCM2 was more sensitive than Ki-67 in identifying colorectal mucosal proliferation. Increased proliferation (assessed either by MCM2 or Ki-67) in mucosa at 10 cm but not at 1 cm from the carcinoma, significantly predicted for origin from a carcinoma-associated colon.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH REGISTER
Journal of Clinical Pathology Molecular Pathology
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2008 by the BMJ Publishing Group Ltd & Association of Clinical Pathologists.